| ABI1 |
Q8IZP0
|
abl interactor 1
|
Enzyme modulator
|
0.64 |
0.641 |
0.538 |
| ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
| ACE |
P12821
|
angiotensin I converting enzyme
|
Enzyme
|
1.0E-37 |
0.328 |
0.923 |
| ACTB |
P60709
|
actin beta
|
Cellular structure
|
0.99 |
0.325 |
0.923 |
| AGGF1 |
Q8N302
|
angiogenic factor with G-patch and FHA domains 1
|
|
2.7E-05 |
0.650 |
0.462 |
| AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
| ALB |
P02768
|
albumin
|
Transporter
|
0.64 |
0.317 |
0.962 |
| ALPI |
P09923
|
alkaline phosphatase, intestinal
|
Enzyme
|
2.5E-18 |
0.563 |
0.769 |
| ALPP |
P05187
|
alkaline phosphatase, placental
|
Enzyme
|
1.8E-13 |
0.487 |
0.808 |
| AMCN |
|
arthrogryposis multiplex congenita, neurogenic
|
|
|
0.682 |
0.615 |
| ASXL1 |
Q8IXJ9
|
ASXL transcriptional regulator 1
|
|
1.3E-14 |
0.482 |
0.808 |
| ATN1 |
P54259
|
atrophin 1
|
|
1.00 |
0.409 |
0.885 |
| AURKA |
O14965
|
aurora kinase A
|
Kinase
|
0.87 |
0.475 |
0.731 |
| BAK1 |
Q16611
|
BCL2 antagonist/killer 1
|
Signaling
|
7.4E-06 |
0.555 |
0.769 |
| BAX |
Q07812
|
BCL2 associated X, apoptosis regulator
|
Signaling
|
0.32 |
0.417 |
0.885 |
| BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
| BCL2L2 |
Q92843
|
BCL2 like 2
|
Signaling
|
0.47 |
0.599 |
0.615 |
| BCL2L2-PABPN1 |
Q92843
|
BCL2L2-PABPN1 readthrough
|
|
0.28 |
0.653 |
0.500 |
| BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
| BID |
P55957
|
BH3 interacting domain death agonist
|
|
1.6E-11 |
0.555 |
0.808 |
| BMF |
Q96LC9
|
Bcl2 modifying factor
|
|
6.8E-03 |
0.663 |
0.423 |
| BMP1 |
P13497
|
bone morphogenetic protein 1
|
|
8.9E-04 |
0.554 |
0.769 |
| BMP6 |
P22004
|
bone morphogenetic protein 6
|
Signaling
|
0.76 |
0.531 |
0.808 |
| BMP7 |
P18075
|
bone morphogenetic protein 7
|
Signaling
|
0.13 |
0.498 |
0.769 |
| BNIP3 |
Q12983
|
BCL2 interacting protein 3
|
|
2.0E-05 |
0.520 |
0.731 |